Kim Susan G.'s most recent trade in Pacific Biosciences of California Inc was a trade of 19,782 Common Stock done at an average price of $1.7 . Disclosure was reported to the exchange on Sept. 30, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pacific Biosciences of Cal... | Susan G. Kim | See Remarks | Sale of securities on an exchange or to another person at price $ 1.72 per share. | 30 Sep 2024 | 19,782 | 695,654 (0%) | 0% | 1.7 | 34,065 | Common Stock |
| Pacific Biosciences of Cal... | Susan G. Kim | See Remarks | Sale of securities on an exchange or to another person at price $ 4.87 per share. | 04 Mar 2024 | 5,275 | 712,260 (0%) | 0% | 4.9 | 25,695 | Common Stock |
| Pacific Biosciences of Cal... | G. Susan Kim | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 432,692 | 715,450 (0%) | 0% | 0 | Common Stock | |
| Pacific Biosciences of Cal... | G. Susan Kim | See Remarks | Sale of securities on an exchange or to another person at price $ 5.96 per share. | 16 Feb 2024 | 22,496 | 283,589 (0%) | 0% | 6.0 | 134,031 | Common Stock |
| Pacific Biosciences of Cal... | Kim Susan G. | See Remarks | Sale of securities on an exchange or to another person at price $ 5.26 per share. | 16 Feb 2024 | 831 | 282,758 (0%) | 0% | 5.3 | 4,372 | Common Stock |
| Pacific Biosciences of Cal... | Susan G. Kim | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 164,200 | 328,550 (0%) | 0% | 0 | Common Stock | |
| Pacific Biosciences of Cal... | Susan G. Kim | See Remarks | Sale of securities on an exchange or to another person at price $ 9.49 per share. | 02 Mar 2023 | 5,045 | 323,505 (0%) | 0% | 9.5 | 47,892 | Common Stock |
| Pacific Biosciences of Cal... | Susan G. Kim | See Remarks | Sale of securities on an exchange or to another person at price $ 10.27 per share. | 17 Feb 2023 | 907 | 162,581 (0%) | 0% | 10.3 | 9,316 | Common Stock |
| Pacific Biosciences of Cal... | Susan G. Kim | See Remarks | Sale of securities on an exchange or to another person at price $ 5.61 per share. | 29 Sep 2022 | 12,968 | 163,488 (0%) | 0% | 5.6 | 72,802 | Common Stock |
| Pacific Biosciences of Cal... | Susan G. Kim | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.06 per share. | 17 Feb 2022 | 1,062 | 134,966 (0%) | 0% | 11.1 | 11,746 | Common Stock |
| Pacific Biosciences of Cal... | Susan G. Kim | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 12,600 | 12,600 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Susan G. Kim | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 6,300 | 156,300 (0%) | 0% | 0 | Common Stock | |
| Pacific Biosciences of Cal... | Susan G. Kim | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2020 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Susan G. Kim | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2020 | 150,000 | 150,000 (0%) | 0% | 0 | Common Stock |